International Assets Investment Management’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
Other funds holding HQL
SCM
PCM
KIM
SIA
AIA
NIM
FHA
1CP
International Assets Investment Management's HQL Position: Q4 2024 in Review
International Assets Investment Management sold out of abrdn Life Sciences Investors (HQL) in Q4 2024, closing a stake of 13,507 shares — an estimated $896 sold.
International Assets Investment Management first reported a position in HQL in Q4 2020 and held it in 8 quarters. The position peaked at $513K in Q1 2021. 72 funds tracked by Wall St. Rank hold HQL as of Q4 2024.
- International Assets Investment Management reported no remaining abrdn Life Sciences Investors position as of Q4 2024 after selling out during the quarter.
- International Assets Investment Management sold 13,507 abrdn Life Sciences Investors shares in Q4 2024, an estimated $896.
- International Assets Investment Management first reported a position in abrdn Life Sciences Investors in Q4 2020 and held it in 8 quarters.
- International Assets Investment Management's abrdn Life Sciences Investors position peaked at $513K in Q1 2021.
- 72 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q4 2024.
Based on International Assets Investment Management's 13F filing for Q4 2024, filed 8 Jan 2025.